Utility of the prostest to predict and monitor response to chemotherapy in metastatic Castration-Resistant prostate cancer: A prospective pilot study by Kambiz Rahbar, Katrin Schlack, Martin Bögemann

Get full text

Real-world treatment patterns and clinical outcomes in patients with locally advanced or metastatic urothelial carcinoma in Germany: retrospective CONVINCE study by Katrin Schlack, Stefan Machtens, Thomas Kubin, Markus Ruhnke, Clemens Schulte, Anna Eisen, Ulrike Osowski, Silke Guenther, Mairead Kearney, Rainer Lipp, Stephan Schmitz

Get full text

Comparison of circulating tumor cells and AR-V7 as clinical biomarker in metastatic castration-resistant prostate cancer patients by Katrin Schlack, Konstantin Egon Seifert, Neele Wüstmann, Verena Humberg, Norbert Grundmann, Julie Steinestel, Dorothee Tiedje, Kambiz Rahbar, Laura-Maria Krabbe, Martin Bögemann, Andres J. Schrader, Christof Bernemann

Get full text

Co-expression and clinical utility of AR-FL and AR splice variants AR-V3, AR-V7 and AR-V9 in prostate cancer by Neele Wüstmann, Konstantin Egon Seifert, Verena Humberg, Julia Vieler, Norbert Grundmann, Julie Steinestel, Dorothee Tiedje, Stefan Duensing, Laura-Maria Krabbe, Martin Bögemann, Andres Jan Schrader, Christof Bernemann, Katrin Schlack

Get full text